m+Medelevator.RU
← Поиск публикаций
Pharmaceutical science advances · 2023

Investigation of wound healing and anti-inflammatory activity of Senna occidentalis leaf extract, and in silico screening for both activities.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Shyeed Md Abu, Al Bashera Mahci, Sazal Ovijit Sarkar, Ali Md Moktar, Hossain Md Polok, Kumar Mondol Henry Sandip, Chowdhury Mohammad Ali, Hossain Khan Rajib, Hossain Molla Md Tamzid

Аннотация

Senna occidentalis, synonym Cassia occidentalis, is a native American pantropical plant species previously classified under the genus Cassia. This study is for testing and to discover new potent phytochemicals from this plant as wound healing and anti-inflammatory agents. The Excision and Assay of Red Blood Cell (RBC) Membrane Stabilization for Anti-Inflammatory Activity Test Method was used to test how well extracts of S. occidentalis leaves from methanol, n-hexane, chloroform, and absolute alcohol helped wounds heal and stopped inflammation. In silico is another method for finding potent phytochemicals for both activities. These leaf extracts effectively cure wound areas and promote re-epithelialization. The methanol extract exhibited maximum wound healing (95.04%) and anti-inflammation (62.94%) activity compared to their other extracts, standard, and control groups. In silico molecular docking of Apigenin, Aloe-emodin with GSK-3B protein, and 1-Methoxynaphthalene, Quinine with COX-2 protein showed binding affinity in (kjJ/mol) of -8.4, -8.6, and -7.3, -7.7, for wound healing and anti-inflammatory activity, respectively, in their binding sites with stability. They support the "Lipinski Rule of Five." This plant leaf extract is recommended as a traditional medicine and an alternative, complementary treatment for its continued contribution to drug discovery and development.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты